---
figid: PMC4462038__CN-13-132_F2
figlink: /pmc/articles/PMC4462038/figure/F2/
number: F2
caption: The different mechanisms of AAS neurotoxicity. In the classical pathway (1),
  the androgen freely passes through the membrane bilayer and binds cytoplasmic Androgen
  Receptor (AR); after translocation to the nucleus bound AR binds to Steroid-Response
  Elements (SRE), stimulating gene transcription. Bound AR also interacts with Src
  Homology Domain 3 (SH3) of the tyrosine kinase c-Src to activate the Mitogen-Activated
  Protein Kinase (MAPK) pathway and induces gene transcription via phosphorylation
  of coactivator/receptor complexes (2). The androgen binds to Steroid Hormone Binding
  Globulin (SHBG) activating the SHBG Receptor (SHBGR) and leading to an increase
  in Protein Kinase A (PKA) activity. PKA may influence AR-mediated transcription
  via alteration of phosphorylation status of AR and AR coregulators (3). AAS can
  be also metabolized to estrogens, interacting not only with AR but also with Estrogen
  Receptors (ERα and ERβ) to regulate gene transcription. These interaction can result
  in change in GABAA receptor subunit gene expression. AAS also induce directly changes
  in GABAergic signaling altering gene expression. On the right the non-genomic androgen
  action via changes in intracellular ion concentrations and membrane fluidity is
  represented. Androgen interacts with a membrane associated AR leading to the activation
  of Ltype calcium channels through some type of inhibitory g-protein (GP). This increase
  in intracellular calcium activates Protein Kinase C (PKC), and activates via calmodulin
  (CAM) PKA and MAPK pathway. The modulation of GP may also activate Phospholipase
  C (PLC) resulting in increases in inositol 1,4,5-thriphosphate (IP3) and consequently
  in release of intracellular calcium stores from the sarcoplasmic reticulum and in
  activation of the RAS/MEK/ERK pathway (MEK=MAPK/ERK kinase, ERK=extracellular-signal
  regulated kinase).
pmcid: PMC4462038
papertitle: 'Neurotoxicity by Synthetic Androgen Steroids: Oxidative Stress, Apoptosis,
  and Neuropathology: A Review.'
reftext: Cristoforo Pomara, et al. Curr Neuropharmacol. 2015 Jan;13(1):132-145.
pmc_ranked_result_index: '179085'
pathway_score: 0.9654977
filename: CN-13-132_F2.jpg
figtitle: Different mechanisms of AAS neurotoxicity
year: '2015'
organisms: Homo sapiens
ndex: af5fb41d-ded0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4462038__CN-13-132_F2.html
  '@type': Dataset
  description: The different mechanisms of AAS neurotoxicity. In the classical pathway
    (1), the androgen freely passes through the membrane bilayer and binds cytoplasmic
    Androgen Receptor (AR); after translocation to the nucleus bound AR binds to Steroid-Response
    Elements (SRE), stimulating gene transcription. Bound AR also interacts with Src
    Homology Domain 3 (SH3) of the tyrosine kinase c-Src to activate the Mitogen-Activated
    Protein Kinase (MAPK) pathway and induces gene transcription via phosphorylation
    of coactivator/receptor complexes (2). The androgen binds to Steroid Hormone Binding
    Globulin (SHBG) activating the SHBG Receptor (SHBGR) and leading to an increase
    in Protein Kinase A (PKA) activity. PKA may influence AR-mediated transcription
    via alteration of phosphorylation status of AR and AR coregulators (3). AAS can
    be also metabolized to estrogens, interacting not only with AR but also with Estrogen
    Receptors (ERα and ERβ) to regulate gene transcription. These interaction can
    result in change in GABAA receptor subunit gene expression. AAS also induce directly
    changes in GABAergic signaling altering gene expression. On the right the non-genomic
    androgen action via changes in intracellular ion concentrations and membrane fluidity
    is represented. Androgen interacts with a membrane associated AR leading to the
    activation of Ltype calcium channels through some type of inhibitory g-protein
    (GP). This increase in intracellular calcium activates Protein Kinase C (PKC),
    and activates via calmodulin (CAM) PKA and MAPK pathway. The modulation of GP
    may also activate Phospholipase C (PLC) resulting in increases in inositol 1,4,5-thriphosphate
    (IP3) and consequently in release of intracellular calcium stores from the sarcoplasmic
    reticulum and in activation of the RAS/MEK/ERK pathway (MEK=MAPK/ERK kinase, ERK=extracellular-signal
    regulated kinase).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLCG2
  - MAPK12
  - MAP2K2
  - PRKCE
  - PRKCG
  - PRKAR2A
  - PRKAR1A
  - PRKAR1B
  - PLCD4
  - PRKACG
  - MAPK13
  - PLCD1
  - PLCG1
  - AR
  - KRIT1
  - PLCZ1
  - HRAS
  - KRAS
  - NRAS
  - MAPK14
  - MAPK1
  - PRKCZ
  - PLCD3
  - PLCB4
  - MAPK10
  - MAPK9
  - PRKD3
  - PRKCA
  - PRKCB
  - MAP2K1
  - PRKACA
  - PRKACB
  - PRKCI
  - PRKCQ
  - PRKAR2B
  - PLCB3
  - PLCB1
  - PLCE1
  - PRKCD
  - ESR2
  - PRKCH
  - MAPK3
  - MAPK8
  - PLCB2
  - MAPK11
  - ESR1
  - GABA
  - Cancer
genes:
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: CAM
  symbol: CAM
  source: hgnc_alias_symbol
  hgnc_symbol: KRIT1
  entrez: '889'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: ERB
  symbol: ER-beta
  source: hgnc_alias_symbol
  hgnc_symbol: ESR2
  entrez: '2100'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERa
  symbol: ER-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: ESR1
  entrez: '2099'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: GABA
  source: MESH
  identifier: D005680
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4462038__F2
redirect_from: /figures/PMC4462038__F2
figtype: Figure
---
